
Ras Reed tells his experience with the new drug “Rasonic” to treat pancreatic cancer after his wife’s campaign on social media
American pancreatic cancer patient Russ Reid says he is seeing promising results from the new drug "Rasonic", which he obtained through his wife's efforts through social media and the Food and Drug Administration's Expanded Access Program.
AI-generated summary
Ras Reid relapsed 4 months after he was declared free of pancreatic cancer, so he resorted to the new drug “Rasonic” after his wife’s campaign through social media.
A pancreatic cancer patient in Florida says he is seeing promising results from a new pancreatic cancer drug, giving him more time with his family while he battles the disease. But getting the medicine wasn't easy. CNN's Randy Kaye caught up with him to find out more details.
In August 2025, Russ Reid celebrated being cancer-free. But just four months later, Ras's pancreatic cancer returned, and this time it had spread to his liver and intestines. Reid says his mutation of the disease is very aggressive, "the most aggressive mutation associated with pancreatic cancer."
He tried chemotherapy, but nothing worked. Then news spread of a brand-new drug called Rasonic, which showed promising results, but had not yet received FDA approval.
His wife, Marnie Reed, was devastated. Her father died of pancreatic cancer at the age of 63, the same age her husband, Russ, was when he was diagnosed with the disease. “I was determined that this would not happen again,” she says. So she took action, sharing the story of her husband's battle with cancer and his inability to get the new medication on social media.
Marnie says the news spread widely, and the FDA called the house. Eventually, Ras obtained the drug through the US Food and Drug Administration's Expanded Access Program. He described it as "hope in a bottle."
Ras says that within just 12 days of starting the new medication, his pain was gone. But the side effects of the rash were “difficult” for him, as it spread to his face, torso, arms and legs, but he is still grateful for the medication.
The drug "is not a cure, but it is a step in the right direction," explained Dr. Jesús Fabregas, an oncologist at Memorial Cancer Institute. He added: "I would like to give this medicine to every patient with pancreatic cancer."
Rasonic is now approved by the US Food and Drug Administration, but is only available to patients with stage 4 pancreatic cancer that has spread to other parts of the body.

Workers in the health sector in Libya are preparing to organize a protest to demand improvement in professional conditions, in conjunction with a government alert to confront an expected weather depression, and judicial investigations into the corruption of water network infrastructure contracts.

The report reviews medical progress in cancer treatment, discusses an academic report on artificial intelligence governance gaps in hospitals, in addition to a Canadian study that reveals the shortcomings of artificial intelligence models in understanding diverse cultural contexts.

The report addresses the challenges of AI governance in medicine, and the shortcomings of models in understanding global cultural contexts, while providing practical advice for using these technologies as a tool to promote critical thinking rather than relying entirely on them.

Recent studies have found biological indicators in the blood to predict prostate cancer 15 years earlier, chosen almonds as the healthiest nut, and discovered a subtype of depression linked to the body's biological clock.

Scientists have revealed a new subtype of depression linked to the biological clock that affects a quarter of patients, in conjunction with a study confirming the success of artificial intelligence in predicting heart disease through polysomnography.

Researchers at the Mass General Brigham Foundation have developed artificial intelligence models that can predict the biological age of cancer patients and their chances of survival using a single facial image, in a technology that may help doctors evaluate health conditions.